Evaluation of the Effectiveness of the Parkinson Specialized Teams Intervention

Recruiting now · Not applicable

Conditions studied: Parkinson Disease

In brief

A pilot experiment interventional study is proposed in order to set up multidisciplinary team for Parkinson's patients at home. The aim of this study is to evaluate the effectiveness of this specialized Parkinson's team (ESPark) intervention a on the quality of life of patients with moderate to severe Parkinson's disease

Key facts

Study ID: NCT05433441
Run by: University Hospital, Bordeaux
People needed: 250
Starts: 2022-12-06
Expected to finish: 2027-06-06
Last updated by the study team: 2025-07-23

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

For the patient:
Patient with a diagnosis of idiopathic Parkinson's disease
Patient over 18 years ;
Patient with a Hoehn and Yahr Stage greater than or equal to 3;
Patient without major cognitive impairment defined by a MOCA score ≥21
Patient living at home ;
Patient with an identified non-professional primary caregiver;
Person affiliated with or benefiting from a social security plan;
Free, informed and and express consent (confirmed in writing) (no later than the day of inclusion and before any examination required by the research).
For the caregiver:
Male or female over 18 years
Able to respond to research interviews/questionnaires
Free, informed and express consent (confirmed in writing) (no later than the day of inclusion and before any examination required by the research).

You may not qualify if…

For the patient:
Patient with medically indicated dementia impairing comprehension and adherence, and/or with severe confusion or psycho-hallucinatory state;
Institutionalized or foster care patients;
Patients with a known severe and unstable general pathology that does not allow for patient follow-up;
Patients already included in another non-drug management trial;
Patients whose institutionalization is envisaged in the short term (within 6 months) or for whom a change of residence is envisaged in the short term and would not allow for follow-up assessments;
Patients under guardianship or unable to express consent
Primary caregiver not wishing to participate in the study or unable to be available for the planned study follow-up;
Presence of a primary caregiver with a known severe and unstable disease that does not allow for the conduct of the study;
Presence of a primary caregiver with a known cognitive or psychiatric disorder (chronic progressive psychosis) that does not allow for the proper conduct of the study.
Pregnant or breastfeeding woman.
For the caregiver:
Unable to follow the research interviews or questionnaires.
Primary caregiver not wishing to participate in the study or unable to be available for the planned study follow-up;
Primary caregiver with a known severe and unstable illness that does not allow for the proper conduct of the study;
Primary caregiver with known cognitive or psychiatric disorders (chronic progressive psychosis) that do not allow the study to be conducted properly.

Where it is running

Hopital Pellegrin — Bordeaux, France (enrolling)
CHU de Lille — Lille, France (enrolling)
CHU de Limoges — Limoges, France (enrolling)
CHU Poitiers — Poitiers, France (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.